E
BHVN icon

Ergoteles’s Biohaven BHVN Stock Holding History

Ergoteles’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-12,775
Closed -$306K – 122
2023
Q2 		$306K Buy
+12,775
New +$220K 0.01% 763

Other funds holding BHVN

Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Ergoteles's BHVN Position: Q3 2023 in Review

Ergoteles sold out of Biohaven (BHVN) in Q3 2023, closing a stake of 12,775 shares — an estimated $306K sold.

Ergoteles first reported a position in BHVN in Q2 2023 and held it in 1 quarter. The position peaked at $306K in Q2 2023. 187 funds tracked by Wall St. Rank hold BHVN as of Q3 2023.

  • Ergoteles reported no remaining Biohaven position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 12,775 Biohaven shares in Q3 2023, an estimated $306K.
  • Ergoteles first reported a position in Biohaven in Q2 2023 and held it in 1 quarter.
  • Ergoteles's Biohaven position peaked at $306K in Q2 2023.
  • 187 funds tracked by Wall St. Rank held Biohaven as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.